Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Etcelera
organization1 mentionslast seen Oct 29, 2026
Drug discovery and development company formed by merger of Cellarity, Etiome, and Empress Therapeutics platforms, combining causal intelligence capabilities with Flagship Pioneering's AI tools.
Relationships 16
- EtceleraemploysAlec Reynolds97% confidence1 source
- EtceleraemploysAd Rawcliffe97% confidence1 source
- Etceleracomposed ofEmpress Therapeutics95% confidence1 source
- Flagship PioneeringdevelopsEtcelera95% confidence1 source
- Etceleracomposed ofCellarity95% confidence1 source
- Etceleracomposed ofEtiome95% confidence1 source
- Etceleradevelopscausal intelligence92% confidence1 source
- Etceleraapplies toimmunology90% confidence1 source
- Etceleraapplies tohematology90% confidence1 source
- Etceleradepends onperturbation data generation90% confidence1 source
- Etceleradepends onAI-powered prediction model90% confidence1 source
- Etceleradepends onchemoproteomics90% confidence1 source
- Etceleradepends ontranscriptomic data analysis90% confidence1 source
- Etceleradepends onfoundation model for drug discovery88% confidence1 source
- Etceleraapplies tometabolic disease treatment88% confidence1 source
- Flagship Pioneeringinvests inEtcelera85% confidence1 source
Relationship
Etceleracomposed ofEmpress Therapeutics
95% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1